Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi

Antimicrob Agents Chemother. 2005 Sep;49(9):3919-21. doi: 10.1128/AAC.49.9.3919-3921.2005.

Abstract

We conducted a prevalence study of mutations in Plasmodium falciparum that are associated with antifolate resistance in Blantyre, Malawi. The dihydrofolate reductase 164-Leu mutation, which confers resistance to both pyrimethamine and chlorproguanil, was found in 4.7% of the samples. Previously unreported mutations in dihydropteroate synthase were also found.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antimalarials / pharmacology*
  • DNA Primers
  • Drug Combinations
  • Drug Resistance
  • Folic Acid Antagonists / pharmacology
  • Humans
  • Malaria, Falciparum / parasitology
  • Malawi
  • Mutation
  • Plasmodium falciparum / drug effects*
  • Plasmodium falciparum / genetics*
  • Proguanil / analogs & derivatives*
  • Proguanil / pharmacology
  • Pyrimethamine / pharmacology*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sulfadoxine / pharmacology*
  • Tetrahydrofolate Dehydrogenase / genetics
  • Tetrahydrofolate Dehydrogenase / metabolism

Substances

  • Antimalarials
  • DNA Primers
  • Drug Combinations
  • Folic Acid Antagonists
  • Sulfadoxine
  • chlorproguanil
  • Tetrahydrofolate Dehydrogenase
  • Proguanil
  • Pyrimethamine